ArticleBMJ public health2026
Association between children's secondhand co-exposure to tobacco and cannabis smoke and elevated urinary cotinine levels: a cross-sectional analysis.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cannabis use is far more common among adults who smoke tobacco than adults who do not, and its use is increasing among people who smoke tobacco with children living in the home. Given the well-established evidence that caregiver smoking is the primary source of children's secondhand exposures to these products, the increasing trend in caregiver co-use is raising public health concerns about children's co-exposure. Emerging data indicates that adult co-use is linked to additive health consequences, such as elevated nicotine and other tobacco-related toxicant blood levels, relative to use of only tobacco. It is unknown whether children's co-exposure leads to similar additive consequences. This study examined whether children's co-exposure to secondhand tobacco and cannabis smoke related to higher urinary levels of cotinine (the primary nicotine metabolite) relative to children exposed to only tobacco smoke. Methods: This study performed a cross-sectional analysis of baseline data from the 'Babies Living Safe and Smokefree' tobacco intervention randomised controlled trial. All participants (N=396) included low-income mothers who smoked tobacco daily and were primary caretakers of young children (<6 years old). Multivariable regression was performed to test the hypothesis that maternal co-smoking would relate to children's elevated cotinine levels in a model including potential confounding variables (eg, children's mean daily tobacco smoke exposure, maternal nicotine dependence level). Results: Mean participant age was 30.11+6.52 years old, and their children's age was 30.24+20.0 months old. In the past 7 days, 146 (36.9%) participants reported smoking cannabis on at least 1 day. Multivariable regression modelling showed that maternal co-smoking was associated with higher children's cotinine levels (p=0.04). Conclusions: Maternal co-use of tobacco and cannabis, relative to tobacco smoking only, is associated with higher cotinine levels in their children. Given that caregiver smoking is the primary source of young children's exposure to both tobacco and cannabis, clinicians and the public could be better informed about the potential additive health risks of co-exposure without diluting existing health messaging and prevention efforts focused on use and exposure risks related to each product independently. Results point to the need for sustained public health efforts to reduce children's exposure to these toxicants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.